Pluristem and U.S. Department of Defense Present Positive Data from Studies Testing PLX-R18 as a Prophylactic Treatment for Acute Radiation Syndrome

NEXT STORY
Forty Seven Inc. to Present at Canaccord Genuity 39th Annual Growth Conference
PREV STORY
Clearside Biomedical Announces Multiple Oral Presentations Delivered at the American Society of Retinal Specialists (ASRS) Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

RedHill Biopharma Announces Peer-Reviewed Publication Demonstrating Therapeutic Potential of YELIVA™ in Cholangiocarcinoma Cancer

The article was authored by scientists from the Mayo Clinic Cancer Center, the Hollings ...

author_avatar
NASDAQ Market News

Intellia Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Developments

Enhanced in vivo CRISPR/Cas9 cargo components have led to substantially increased liver editing and ...

author_avatar
NASDAQ Market News

Yamana Gold Reports Strong First Quarter 2021 Production Results and Cash Flows; Canadian Malartic and Minera Florida Post Standout Quarters; Jacobina Achieves All-Time Monthly High Production in March; Adopts Comprehensive Tailings Management Strategy at Jacobina that Includes Hydraulic Backfill; Identifies Potentially Significant Extension to East Gouldie Zone

author_avatar
NASDAQ Market News